|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.00278084
|
|
|
myopathy with deficiency of succinate dehydrogenase and aconitase
|
[NCBI]
|
0.00180597
|
|
|
CF
|
[NCBI]
|
0.00118453
|
|
|
MB
|
[NCBI]
|
0.000786217
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
0.000440052
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
0.000274037
|
|
|
UCP3
|
[NCBI]
|
0.000254607
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
0.00023911
|
|
|
CGD
|
[NCBI]
|
0.000191773
|
|
|
UCP1
|
[NCBI]
|
0.000170718
|
|
|
LAD
|
[NCBI]
|
0.0001615
|
|
|
MERRF
|
[NCBI]
|
0.000144852
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
0.000138215
|
|
|
HBB
|
[NCBI]
|
0.000134233
|
|
|
AVP
|
[NCBI]
|
0.000125241
|
|
|
granulomatous disease with defect in neutrophil chemotaxis
|
[NCBI]
|
9.8592e-05
|
|
|
carnitine acetyltransferase deficiency
|
[NCBI]
|
9.8592e-05
|
|
|
hypermetabolism due to defect in mitochondria
|
[NCBI]
|
9.8592e-05
|
|
|
UCP2
|
[NCBI]
|
9.67421e-05
|
|
|
MTTK
|
[NCBI]
|
9.64648e-05
|
|
|
CAT
|
[NCBI]
|
9.36974e-05
|
|
|
EPO
|
[NCBI]
|
8.87454e-05
|
|
|
XDH
|
[NCBI]
|
8.46885e-05
|
|
|
methane production
|
[NCBI]
|
8.13742e-05
|
|
|
RA
|
[NCBI]
|
7.8886e-05
|
|
|
PPARGC1A
|
[NCBI]
|
7.78621e-05
|
|
|
MPO
|
[NCBI]
|
7.4263e-05
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
7.23509e-05
|
|
|
fumarase deficiency
|
[NCBI]
|
7.23509e-05
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
6.90326e-05
|
|
|
LSFC
|
[NCBI]
|
6.90326e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
6.37228e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
6.37228e-05
|
|
|
mitochondrial myopathy
|
[NCBI]
|
6.37228e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
5.95582e-05
|
|
|
KSS
|
[NCBI]
|
5.42103e-05
|
|
|
LAM
|
[NCBI]
|
5.27006e-05
|
|
|
MTTL1
|
[NCBI]
|
5.20785e-05
|
|
|
NGFB
|
[NCBI]
|
5.18514e-05
|
|
|
LEP
|
[NCBI]
|
5.18177e-05
|
|
|
LPL
|
[NCBI]
|
4.77097e-05
|
|
|
MTCO1
|
[NCBI]
|
4.69289e-05
|
|
|
ADRB2
|
[NCBI]
|
4.64719e-05
|
|
|
MTCYB
|
[NCBI]
|
4.43563e-05
|
|
|
EGF
|
[NCBI]
|
4.39212e-05
|
|
|
ITGB2
|
[NCBI]
|
4.04737e-05
|
|
|
NPY
|
[NCBI]
|
3.80045e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
3.77178e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
3.77178e-05
|
|
|
PDCD8
|
[NCBI]
|
3.72652e-05
|
|
|
PLIN
|
[NCBI]
|
3.64734e-05
|
|
|
ADRB1
|
[NCBI]
|
3.64734e-05
|
|
|
CYBA
|
[NCBI]
|
3.64734e-05
|
|
|
LPGAT1
|
[NCBI]
|
3.64508e-05
|
|
|
CHRM3
|
[NCBI]
|
3.64508e-05
|
|
|
SLC25A30
|
[NCBI]
|
3.64508e-05
|
|
|
OPA1
|
[NCBI]
|
3.60583e-05
|
|
|
AMPD1
|
[NCBI]
|
3.27584e-05
|
|
|
PMCH
|
[NCBI]
|
3.17195e-05
|
|
|
GPBAR1
|
[NCBI]
|
2.82162e-05
|
|
|
UQCRC2
|
[NCBI]
|
2.82162e-05
|
|
|
ACAA2
|
[NCBI]
|
2.82162e-05
|
|
|
NGB
|
[NCBI]
|
2.67644e-05
|
|
|
NIDDM
|
[NCBI]
|
2.62898e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.59978e-05
|
|
|
ATP5C1
|
[NCBI]
|
2.51161e-05
|
|
|
IARS
|
[NCBI]
|
2.51161e-05
|
|
|
MTTY
|
[NCBI]
|
2.31075e-05
|
|
|
GAPDHS
|
[NCBI]
|
2.31075e-05
|
|
|
NDUFA1
|
[NCBI]
|
2.31075e-05
|
|
|
COX15
|
[NCBI]
|
2.31075e-05
|
|
|
NT5E
|
[NCBI]
|
2.31075e-05
|
|
|
CRH
|
[NCBI]
|
2.22454e-05
|
|
|
ADORA2B
|
[NCBI]
|
2.16173e-05
|
|
|
POU2F3
|
[NCBI]
|
2.16173e-05
|
|
|
AK2
|
[NCBI]
|
2.16173e-05
|
|
|
WRN
|
[NCBI]
|
2.15117e-05
|
|
|
NOS3
|
[NCBI]
|
2.09453e-05
|
|
|
NPPA
|
[NCBI]
|
2.06577e-05
|
|
|
VGF
|
[NCBI]
|
2.04323e-05
|
|
|
MTTN
|
[NCBI]
|
2.04323e-05
|
|
|
NMU
|
[NCBI]
|
2.00873e-05
|
|
|
ZS
|
[NCBI]
|
1.96918e-05
|
|
|
TRMU
|
[NCBI]
|
1.94491e-05
|
|
|
H6PD
|
[NCBI]
|
1.91445e-05
|
|
|
PCNA
|
[NCBI]
|
1.87801e-05
|
|
|
SOD2
|
[NCBI]
|
1.86125e-05
|
|
|
ADORA1
|
[NCBI]
|
1.86093e-05
|
|
|
ACHE
|
[NCBI]
|
1.82496e-05
|
|
|
VIP
|
[NCBI]
|
1.82155e-05
|
|
|
1-@aminocyclopropane-1-carboxylate synthase
|
[NCBI]
|
1.78767e-05
|
|
|
EDNRA
|
[NCBI]
|
1.78767e-05
|
|
|
AR
|
[NCBI]
|
1.74766e-05
|
|
|
SCO2
|
[NCBI]
|
1.72272e-05
|
|
|
HTN3
|
[NCBI]
|
1.72272e-05
|
|
|
KCNMA1
|
[NCBI]
|
1.72272e-05
|
|
|
SLE
|
[NCBI]
|
1.71084e-05
|
|
|
FRDA
|
[NCBI]
|
1.69468e-05
|
|
|
PPP2R4
|
[NCBI]
|
1.66443e-05
|
|
|
MDM1
|
[NCBI]
|
1.66443e-05
|
|
|
ACO2
|
[NCBI]
|
1.66443e-05
|
|
|
KCNMB1
|
[NCBI]
|
1.66443e-05
|
|
|
DIO2
|
[NCBI]
|
1.61157e-05
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
1.61157e-05
|
|
|
LEPR
|
[NCBI]
|
1.58565e-05
|
|
|
SCD
|
[NCBI]
|
1.53351e-05
|
|
|
YY1
|
[NCBI]
|
1.47749e-05
|
|
|
HGF
|
[NCBI]
|
1.45794e-05
|
|
|
GFAP
|
[NCBI]
|
1.45198e-05
|
|
|
MTND4L
|
[NCBI]
|
1.4391e-05
|
|
|
EPAS1
|
[NCBI]
|
1.4391e-05
|
|
|
PNPLA2
|
[NCBI]
|
1.40319e-05
|
|
|
ATP1A2
|
[NCBI]
|
1.40319e-05
|
|
|
PPARG
|
[NCBI]
|
1.39265e-05
|
|
|
LPO
|
[NCBI]
|
1.36692e-05
|
|
|
CBL
|
[NCBI]
|
1.3377e-05
|
|
|
NCOA1
|
[NCBI]
|
1.3377e-05
|
|
|
ACADVL
|
[NCBI]
|
1.3377e-05
|
|
|
ADRB3
|
[NCBI]
|
1.30767e-05
|
|
|
DDC
|
[NCBI]
|
1.24104e-05
|
|
|
DBH
|
[NCBI]
|
1.22642e-05
|
|
|
FOXC2
|
[NCBI]
|
1.22642e-05
|
|
|
BDNF
|
[NCBI]
|
1.17356e-05
|
|
|
PRL
|
[NCBI]
|
1.16016e-05
|
|
|
MTCO3
|
[NCBI]
|
1.15584e-05
|
|
|
CHS
|
[NCBI]
|
1.14167e-05
|
|
|
AD
|
[NCBI]
|
1.13369e-05
|
|
|
OPA1
|
[NCBI]
|
1.11351e-05
|
|
|
KL
|
[NCBI]
|
1.09356e-05
|
|
|
SLC25A4
|
[NCBI]
|
1.07434e-05
|
|
|
NCOA2
|
[NCBI]
|
1.0558e-05
|
|
|
CFTR
|
[NCBI]
|
1.04776e-05
|
|
|
IRS2
|
[NCBI]
|
1.03791e-05
|
|
|
AK1
|
[NCBI]
|
1.02061e-05
|
|
|
MTRNR1
|
[NCBI]
|
1.02061e-05
|
|
|
MTND6
|
[NCBI]
|
1.00388e-05
|
|
|
MTCO2
|
[NCBI]
|
9.56749e-06
|
|
|
EDNRB
|
[NCBI]
|
9.00076e-06
|
|
|
PTH
|
[NCBI]
|
8.98498e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
8.92501e-06
|
|
|
EDN1
|
[NCBI]
|
8.86863e-06
|
|
|
CHAT
|
[NCBI]
|
8.75784e-06
|
|
|
SLC16A1
|
[NCBI]
|
8.73996e-06
|
|
|
G6PD
|
[NCBI]
|
8.67949e-06
|
|
|
VEGF
|
[NCBI]
|
8.50821e-06
|
|
|
TNF
|
[NCBI]
|
8.28788e-06
|
|
|
GSR
|
[NCBI]
|
8.25678e-06
|
|
|
MTATP6
|
[NCBI]
|
8.14318e-06
|
|
|
MTND1
|
[NCBI]
|
7.51344e-06
|
|
|
FXN
|
[NCBI]
|
7.41625e-06
|
|
|
CCK
|
[NCBI]
|
7.27586e-06
|
|
|
HBD
|
[NCBI]
|
6.87284e-06
|
|
|
IGF1
|
[NCBI]
|
6.7883e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
6.5611e-06
|
|
|
PRLH
|
[NCBI]
|
6.38824e-06
|
|
|
ADM
|
[NCBI]
|
5.9841e-06
|
|
|
THRB
|
[NCBI]
|
5.81636e-06
|
|
|
RP
|
[NCBI]
|
5.33207e-06
|
|
|
GPI
|
[NCBI]
|
5.06408e-06
|
|
|
NMB
|
[NCBI]
|
4.9738e-06
|
|
|
CP
|
[NCBI]
|
4.69304e-06
|
|
|
INS
|
[NCBI]
|
4.41482e-06
|
|
|
WAS
|
[NCBI]
|
4.03906e-06
|
|
|
PC
|
[NCBI]
|
3.85819e-06
|
|
|
PAM
|
[NCBI]
|
3.59005e-06
|
|
|
COMT
|
[NCBI]
|
3.52648e-06
|
|
|
UCN
|
[NCBI]
|
3.5173e-06
|
|
|
ATM
|
[NCBI]
|
3.48154e-06
|
|
|
PNPLA6
|
[NCBI]
|
3.05047e-06
|
|
|
TH
|
[NCBI]
|
2.97966e-06
|
|
|
POMC
|
[NCBI]
|
2.51891e-06
|
|
|
HP
|
[NCBI]
|
2.13948e-06
|
|
|
ACE
|
[NCBI]
|
2.09061e-06
|
|
|
SHBG
|
[NCBI]
|
1.91297e-06
|
|
|
AHR
|
[NCBI]
|
1.80143e-06
|
|
|
APOB
|
[NCBI]
|
1.76256e-06
|
|
|
PEDF
|
[NCBI]
|
1.59799e-06
|
|
|
GRP
|
[NCBI]
|
1.56435e-06
|
|
|
PD
|
[NCBI]
|
1.27926e-06
|
|
|
PYY
|
[NCBI]
|
1.2493e-06
|
|
|
KCNH2
|
[NCBI]
|
1.21736e-06
|
|
|
DHFR
|
[NCBI]
|
1.15192e-06
|
|
|
PPARA
|
[NCBI]
|
1.04024e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.91055e-07
|
|
|
SLC6A3
|
[NCBI]
|
9.44191e-07
|
|
|
CNTF
|
[NCBI]
|
8.81913e-07
|
|
|
ADA
|
[NCBI]
|
8.38018e-07
|
|
|
HBA1
|
[NCBI]
|
6.5783e-07
|
|
|
TP53
|
[NCBI]
|
5.99071e-07
|
|
|
PNMT
|
[NCBI]
|
5.43995e-07
|
|
|
ADCYAP1
|
[NCBI]
|
5.39812e-07
|
|
|
PI
|
[NCBI]
|
5.14108e-07
|
|
|
FRAP1
|
[NCBI]
|
2.90382e-07
|
|
|
PWS
|
[NCBI]
|
2.89106e-07
|
|
|
SLC6A4
|
[NCBI]
|
2.57519e-07
|
|
|
LCAT
|
[NCBI]
|
2.43589e-07
|
|
|
RNASE3
|
[NCBI]
|
1.96776e-07
|
|
|
STAT3
|
[NCBI]
|
1.38335e-07
|
|
|
TF
|
[NCBI]
|
1.2522e-07
|
|
|
GIP
|
[NCBI]
|
1.16559e-07
|
|
|
ALB
|
[NCBI]
|
9.69822e-08
|
|
|
GAPDH
|
[NCBI]
|
5.92662e-08
|
|
|
FA
|
[NCBI]
|
1.01554e-08
|
|
|
PF4
|
[NCBI]
|
2.17719e-09
|
|